Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.
710 Medtronic Pkwy
Minneapolis, MN 55432-5604
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
Technology | Drug-Eluting Balloons | June 15, 2018
Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of the In.Pact...
Feature | Ventricular Assist Devices (VAD) | June 04, 2018
June 4, 2018 — The U.S.
News | Stents Drug Eluting | May 29, 2018
Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing strong early...
News | Stents Bifurcation | May 29, 2018
Medtronic plc announced the initiation of a U.S. clinical study to assess the safety and efficacy of drug-eluting...
News | Pacemakers | May 24, 2018
Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System Detects Atrial Contractions, Restores AV Synchrony
New clinical study results demonstrate that an investigational algorithm, utilizing the accelerometer signal in the...
News | Leads Implantable Devices | May 24, 2018
Medtronic plc announced results from a research study demonstrating the feasibility of a novel approach to delivering...
News | Renal Denervation | May 23, 2018
At the 2018 EuroPCR Annual Meeting in Paris, Medtronic announced first-ever-data from the SPYRAL HTN-ON MED Study....